Condition: Palliative Care · Sponsor: Murdoch Childrens Research Institute
The goal of this pilot study is to explore the feasibility and acceptability of a medicinal cannabis clinical trial into easing the symptoms of children undergoing palliative care for non-oncological conditions. The trial will evaluate the study design including recruitment strategy, medication tolerability, duration and outcomes to determine acceptability and feasibility for participating families. The data collected will then be used to design a full-scale multi-centre trial. Participants will be randomly allocated to receive one of two medicinal cannabis products. Neither the participants nor researchers will know the study drug allocation until the end of the trial.
This description comes directly from the study's public registry record.
A/Prof Daryl Efron · +61 (3) 8341 6200 · mctrials@mcri.edu.au
Clinical Trial Coordinator · +61 (3) 8341 6200 · mctrials@mcri.edu.au
Always discuss trial participation with your own doctor first.
| Royal Children's Hospital / Murdoch Children's Research Institute | Parkville, Victoria, Australia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05615389